DAWNRAYS PHARMA: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE DISPOSAL OF INTERESTS IN A JOINT VENTURE COMPANY
DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION-DISPOSAL OF INTERESTS IN A JOINT VENTURE COMPANY
DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION - PROVISION OF FINANCIAL ASSISTANCE
DAWNRAYS PHARMA: (1) DISCLOSEABLE TRANSACTION-DISPOSAL OF EQUITY INTERESTS IN THE TARGET COMPANY;(2) UPDATE ON GAIN ON PREVIOUS DISPOSAL
DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION - PROVISION OF FINANCIAL ASSISTANCE
DAWNRAYS PHARMA: UPDATE ON JOINT VENTURE COMPANY-EARLY COMPLETION OF PATIENT ENROLLMENT IN PHASE IIB CLINICAL TRIAL FOR EBRONUCIMAB (PCSK9 INHIBITORS) FOR TREATING PATIENTS SUFFERING FROM HIGH- OR VERY HIGH-RISK HYPERCHOLESTEROLEMIA IN THE PRC
DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION-CONSTRUCTION AGREEMENTS
DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION -CONSTRUCTION AGREEMENT
DAWNRAYS PHARMA: UPDATE ON JOINT VENTURE COMPANY AND SUPPLEMENTAL AGREEMENT TO JV AGREEMENT
DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION MARKETING AUTHORIZATION HOLDER (MAH) IN RESPECT OF FEBUXOSTAT
DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION-COMPLETION OF THE ACQUISITION OF TOP FIELD LIMITED
DAWNRAYS PHARMA: UPDATE TO DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF TOP FIELD LIMITED
No Data